StrideBio Overview

Founded 2016
Status Private
Employees 38
Latest Deal Type Corporate
Latest Deal Amount $48M
Latest Deal Amount
Investors 6

StrideBio General Information


Developer of a biotechnology platform designed for creating and developing novel adeno-associated viral vector technologies. The company's platform combines structural information with accelerated evolution to create novel AAV capsids that can evade neutralizing antibodies, enabling medical scientists to access a drug discovery platform that can be applied to all AAV serotypes, including both natural and engineered AAV capsids.

Contact Information

Formerly Known As
Stride Therapeutics
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Industries
Drug Discovery
Primary Office
  • PO 110321
  • Suite 200
  • Durham, NC 27709
  • United States
+1 (984) 000-0000

StrideBio Timeline

Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

StrideBio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Corporate 14-Nov-2019 $48M 000.00 Completed Generating Revenue
1. Early Stage VC (Series A) 13-Jun-2018 000.00 000.00 000.00 Completed Startup

StrideBio Cap Table

To view StrideBio‘s complete cap table, request access »
Stock # of Shares
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000

StrideBio Executive Team (7)

Name Title Board Seat Contact Info
Sapan Shah Ph.D Chief Executive Officer & Board Member
Patrick Ritschel Co-Founder, President & Board Member
Maritza McIntyre Ph.D Chief Development Officer
Aravind Asokan Ph.D Co-Founder & Board Member
Mavis Agbandje-McKenna Ph.D Co-Founder

1 Former Executive

StrideBio Board Members (8)

To view StrideBio‘s full board member team, request access »
Name Representing Role Since
Aravind Asokan Ph.D StrideBio Co-Founder & Board Member 000 0000
Clay Thorp Hatteras Venture Partners Board Member 000 0000
Erica Whittaker Ph.D UCB Ventures Board Member 000 0000
H. Stewart Parker Self Board Member 000 0000
Jayson Punwani Ph.D Takeda Ventures Board Member 000 0000

StrideBio Investors (6)

To view StrideBio‘s full investor history, request access »
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Sarepta Therapeutics Corporation Minority 000 0000 000000 0
Alexandria Venture Investments Corporate Venture Capital Minority 000 0000 000000 0
Carolina Research Ventures University Minority 000 0000 000000 0
Hatteras Venture Partners Venture Capital Minority 000 0000 000000 0
Takeda Ventures Corporate Venture Capital Minority 000 0000 000000 0

Ready to get started?

Request a free trial